BioMarin Pharmaceutical Inc. Common Stock (BMRN)

Typically moves ±3.96% on earnings
EARNINGS ANALYTICS
event_note Approx. Next Earnings: ~2026-10-28 APPROXIMATE
search

BioMarin Pharmaceutical Inc. Common Stock (BMRN) has a 21-report earnings history dating back to Jul 28, 2021. Its average absolute post-earnings move is ±3.96%, and 47.6% of those reactions were positive. Its largest post-earnings gain was +9.12% (Oct 27, 2021) and its largest decline was -9.93% (Apr 24, 2024). The next earnings report is predicted for 2026-10-28 (approximate).

Earnings reactions

How BMRN moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

21

Avg Abs. Movement

±3.96%

Positive %

47.6%

Negative %

52.4%

Historical Earnings Statistics

Date Timing Earnings move SEC Filing
Aug 06, 2026 ☽ POST +3.76% open_in_new
May 04, 2026 ☽ POST -3.95% open_in_new
Feb 23, 2026 ☽ POST -0.14% open_in_new
Oct 27, 2025 ☽ POST +1.39% open_in_new
event

Earnings Count

21

Total earnings in dataset

trending_up

Avg Abs. Movement

±3.96%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 38 →
38
Funds holding
$2511570845
Total value held
Buying
25 added · 13 reduced
Blackrock, Inc.
$1181173932 -54.38%
State Street Corp
$461152981 +21.77%
Northern Trust Corp
$89154711 -1.78%
Morgan Stanley
$87643066 +6.34%
Ubs Group Ag
$78177385 NEW BUY

Frequently asked about BMRN earnings

When does BioMarin Pharmaceutical Inc. Common Stock report earnings next? expand_more

BioMarin Pharmaceutical Inc. Common Stock (BMRN)'s next earnings date is approximate for 2026-10-28. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does BMRN stock move after earnings? expand_more

Over 21 reports, BMRN has moved an average of ±3.96% the session after earnings, closing higher 47.6% of the time.

What was BMRN's biggest post-earnings move? expand_more

BMRN's largest post-earnings gain on record was +9.12% on Oct 27, 2021, and its largest decline was -9.93% on Apr 24, 2024.

Where can I find BioMarin Pharmaceutical Inc. Common Stock's SEC filings? expand_more

All of BioMarin Pharmaceutical Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.